RUNX1 Research Program is the world's only foundation supporting patients with RUNX1 Familial Platelet Disorder (RUNX1-FPD), a rare hereditary disease that affects blood platelets and can lead to other health concerns. Most notably, individuals with RUNX1-FPD have a 30 times higher risk of developing blood cancer compared to the general population. We fund innovative research focused on blood cancer prevention, and provide educational initiatives as well as opportunities for patients and their families to share their voices with researchers and clinicians.
| Website | http://www.runx1-fpd.org |
| Employees | 8 (2 on RocketReach) |
| Founded | 2015 |
| Address | 1482 East Valley Road 137, Santa Barbara, California 93109, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+27 more
(view full list)
|
| Industry | Philanthropic Fundraising Services |
| Keywords | Platelet Disorders, Rare Blood Disorders, Blood Clotting Disorders, Bleeding Disorders, Blood Disease Research, Rare Disease Research, Rare Disease Support, Inherited Bleeding Disorders, Pediatric Hematology, Patient Advocacy Group, Hematologic Malignancies, Medical Research Foundation, Nonprofit Health Organization, Health Research Funding, Hematopoietic Stem Cell |
| Competitors | Massachusetts General Hospital, Mayo Clinic, Bristol Myers Squibb, Johns Hopkins Medicine, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Fred Hutch, Incyte, National Cancer Institute (NCI), LLS Mid-Atlantic Region +48 more (view full list) |
Looking for a particular RUNX1 Research Program employee's phone or email?
Amanda Eggen is the Director of Patient Engagement and Clinical Programs of RUNX1 Research Program.
2 people are employed at RUNX1 Research Program.
RUNX1 Research Program is based in Santa Barbara, California.